SEARCH

SEARCH BY CITATION

References

  • 1
    Ungo JR, Jones D, Ashkin D, Hollender ES, Bernstein D, Albanese AP, Pitchenik AE. Antituberculous drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus. Am J Respir Crit Care Med 1998; 157: 18711876.
  • 2
    Wong WM, Wu PC, Yuen MF, Cheng CC, Yew WW, Wong PC, Tam CM, et al. Antituberculous drug-related liver dysfunction in chronic hepatitis B infection. HEPATOLOGY 2000; 31: 201206.
  • 3
    Pol SP, Cavalcanti R, Carnot F, Legendre C, Driss F, Chaix ML, Thervet E, et al. Azathioprine hepatitis in kidney transplant recipients. A predisposing role of viral hepatitis. Transplantation 1996; 61: 17741776.
  • 4
    Mourad G, Bories P, Berthelemy C, Barneon G, Michel H, Mion C. Peliosis hepatis and nodular regenerative hyperplasia of the liver in renal transplants. Is cytomegalovirus the cause of this severe disease? Transplant Proc 1987; 19: 36973698.
  • 5
    Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections. HEPATOLOGY 2002; 35: 182189.
  • 6
    Wit FWNM, Weverling GJ, Weel J, Jurriaans S, Lange JMA. Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy. J Infect Dis 2002; 186: 2331.
  • 7
    Berson A, Gervais A, Cazals D, Boyer N, Durand F, Bernuau J, Marcellin P, et al. Hepatitis after buprenorphine misuse in heroin addicts. J Hepatol 2001; 34: 346350.
  • 8
    Riley TR III, Smith JP. Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis C: a case series. Am J Gastroenterol 1998; 93: 15631565.
    Direct Link:
  • 9
    Starko KM, Mullick FG. Hepatic and cerebral pathology findings in children with fatal salicylate intoxication: further evidence for a causal relation between salicylate and Reye's syndrome. Lancet 1983; 1: 326329.
  • 10
    Rosenberg DM, Meyer AA, Manning IH Jr, Neelon FA. Acetaminophen and hepatic dysfunction in infectious mononucleosis. South Med J 1977; 70: 660661.
  • 11
    Ackerman Z, Flugelman MY, Wax Y, Shouval D, Levy M. Hepatitis during measles in young adults: possible role of antipyretic drugs. HEPATOLOGY 1989; 10: 203206.
  • 12
    Polson JE, Ocama P, Larson AM, Hynan L, Lalani EK, Harrison ME, Lee WM. Role of acetaminophen in acute liver failure due to viral hepatitis. HEPATOLOGY 2003; 38: 544A.
  • 13
    MacDonald MG, McGrath PP, McMartin DN, Washington GC, Hudak G. Potentiation of the toxic effects of acetaminophen in mice by concurrent infection with influenza B virus: a possible mechanism for Reye's syndrome. Pediatr Res 1984; 18: 181187.
  • 14
    Pessayre D, Feldmann G, Haouzi D, Fau D, Moreau A, Neuman M. Hepatocyte apoptosis triggered by natural substances (cytokines, other endogenous substances and foreign toxins). In: CameronRG, FeuerG, eds. Apoptosis and Its Modulation by Drugs. Heidelberg: Springer Verlag, 2000: 59108.
  • 15
    Martinez-Lorenzo MJ, Anel A, Gamen S, Monleon I, Lasierra P, Larrad L, Pineiro A, Alava MA, et al. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J Immunol 1999; 163: 12741281.
  • 16
    Feldmann G, Haouzi D, Moreau A, Durand-Schneider AM, Bringuier A, Berson A, Mansouri A, et al. Opening of the mitochondrial permeability transition pore causes matrix expansion and outer membrane rupture in Fas-mediated hepatic apoptosis in mice. HEPATOLOGY 2000; 31: 674683.
  • 17
    Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, Yagita H, et al. Perforin, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol 1997; 158: 52835291.
  • 18
    Mita E, Hayashi N, Lio S, Takehara T, Hijioka T, Kasahara A, Fusamoto H, et al. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun 1994; 204: 468474.
  • 19
    Pessayre D, Larrey D, Biour M. Drug-induced liver injury. In: BircherJ, BenhamouJP, McIntyreN, RizzettoM, RodesJ, eds. Oxford Textbook of Clinical Hepatology. 2nd ed. Oxford, UK: Oxford University Press, 1999: 12611316.
  • 20
    Schiodt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. New Engl J Med 1997; 337: 11121117.
  • 21
    Vermeulen NPE, Bessems JGM, Van De Straat R. Molecular aspects of paracetamol-induced hepatotoxicity and its mechanism-based prevention. Drug Metab Rev 1992; 24: 367407.
  • 22
    Pessayre D, Dolder A, Artigou JY, Wandscheer JC, Descatoire V, Degott C, Benhamou JP. Effect of fasting on metabolite-mediated hepatotoxicity in the rat. Gastroenterology 1979; 77: 264271.
  • 23
    Moore M, Thor H, Moore G, Nelson S, Moldeus P, Orrenius S. The toxicity of acetaminophen and N-acetyl-p-benzoquinone imine in isolated hepatocytes is associated with thiol depletion and increased cytosolic Ca2+. J Biol Chem 1985; 260: 1303513040.
  • 24
    Knight TR, Ho YS, Farhood A, Jaeschke H. Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glutathione. J Pharmacol Exp Ther 2002; 303: 468475.
  • 25
    Demeilliers C, Maisonneuve C, Grodet A, Mansouri A, NGuyen R, Tinel M, Letteron P, et al. Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice. Gastroenterology 2002; 123: 12781290.
  • 26
    Fau D, Lekehal M, Farrell G, Moreau A, Moulis C, Feldmann G, Haouzi D, et al. Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology 1997; 113: 13341346.
  • 27
    Tinel M, Robin MA, Doostzadeh J, Maratrat M, Ballet F, Fardel N, El Kahhwaji J, et al. The interleukin-2 receptor down-regulates the expression of cytochrome P450 in cultured rat hepatocytes. Gastroenterology 1995; 109: 15891599.
  • 28
    Berson A, de Beco V, Letteron P, Robin MA, Moreau C, El Kahwaji J, Verthier N, et al. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 1998; 114: 764774.
  • 29
    Seelig GF, Meister A. Glutathione biosynthesis; γ-glutamylcysteine synthetase from rat kidney. Methods Enzymol 1985; 113: 379390.
  • 30
    Pessayre D, Wandscheer JC, Cobert B, Level R, Degott C, Batt AM, Martin N, et al. Additive effects of inducers and fasting on acetaminophen hepatotoxicity. Biochem Pharmacol 1980; 29: 219223.
  • 31
    Nieto N, Mari M, Cederbaum AI. Cytochrome P450 2E1 responsiveness in the promoter of glutamate-cysteine ligase catalytic subunit. HEPATOLOGY 2003; 37: 96106.
  • 32
    Franklin CC, Krejsa CM, Pierce RH, White CC, Fausto N, Kavanagh TJ. Caspase-3-dependent cleavage of the glutamate-L-cysteine ligase catalytic subunit during apoptotic cell death. Am J Pathol 2002; 160: 18871894.
  • 33
    Lawson JA, Fisher MA, Simmons CA, Farhood A, Jaeschke H. Inhibition of Fas receptor (CD95)-induced hepatic caspase activation and apoptosis by acetaminophen in mice. Toxicol Appl Pharmacol 1999; 156: 179186.
  • 34
    Knight TR, Jaeschke H. Acetaminophen-induced inhibition of Fas receptor-mediated liver cell apoptosis: mitochondrial dysfunction versus glutathione depletion. Toxicol Appl Pharmacol 2002; 181: 133141.
  • 35
    Orrenius S, Zhivotovski B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003; 4: 552565.
  • 36
    Esterline RL, Ray SD, Ji S. Reversible and irreversible inhibition of hepatic mitochondrial respiration by acetaminophen and its toxic metabolite, N-acetyl-p-benzoquinoneimine (NAPQI). Biochem Pharmacol 1989; 38: 23872390.
  • 37
    Qiu Y, Benet LZ, Burlingame AL. Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry. J Biol Chem 1998; 273: 1794017953.
  • 38
    Burcham PC, Harman AW. Acetaminophen toxicity results in site-specific mitochondrial damage in isolated mouse hepatocytes. J Biol Chem 1991; 266: 50495054.
  • 39
    Knight TR, Kurtz A, Bajt ML, Hinson JA, Jaeschke H. Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress. Toxicol Sci 2001; 62: 212220.
  • 40
    Gardner CR, Heck DE, Yang CS, Thomas PE, Zhang XJ, DeGeorge GL, Laskin JD, et al. Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat. HEPATOLOGY 1998; 26: 748754.
  • 41
    Hinson JA, Pike SL, Pumford NR, Mayeux PR. Nitrotyrosine-protein adducts in hepatic centrilobular areas following toxic doses of acetaminophen in mice. Chem Res Toxicol 1998; 11: 604607.
  • 42
    Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997; 185: 14811486.
  • 43
    Ferret PJ, Hammoud R, Tulliez M, Tran A, Trebeden H, Jaffray P, Malassagne B, et al. Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. HEPATOLOGY 2001; 33: 11731180.
  • 44
    Hatano E, Bennett BL, Manning AM, Qian T, Lemasters JJ, Brenner DA. NF-κB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-α and Fas-mediated apoptosis. Gastroenterology 2001; 120: 12511262.
  • 45
    Timbrell JA, Mitchell JR, Snodgrass WR, Nelson SD. Isoniazid hepatotoxicity: the relationship between covalent binding and metabolism in vivo. J Pharmacol Exp Ther 1980; 213: 364369.
  • 46
    Berson A, Fau D, Fornacciari R, Degove-Goddard P, Sutton A, Descatoire V, Haouzi D, et al. Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation. J Hepatol 2001; 34: 261269.
  • 47
    Lee AU, Farrell GC. Mechanism of azathioprine-induced injury to hepatocytes: roles of glutathione depletion and mitochondrial injury. J Hepatol 2001; 35: 756764.
  • 48
    Pessayre D, Mansouri B, Fromenty B, Berson A. Hepatotoxicity due to mitochondrial injury. In: KaplowitzN, DeLeveL, eds. Drug-induced Liver Disease. New York: Marcel Dekker, 2002: 5584.
  • 49
    Oh KW, Qian T, Brenner DA, Lemasters JJ. Salicylate enhances necrosis and apoptosis mediated by the mitochondrial permeability transition. Toxicol Sci 2003; 73: 4452.
  • 50
    Gibbs JS, Malide D, Hornung F, Bennink JR, Yewdell JW. The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J Virol 2003; 77: 72147224.